Interview with Arnaud Nouvion
Gene Drives will most probably be released first to fight malaria. We therefore created this series of interviews with health care experts, researchers and civil society to amplify their voices and concerns around this technology.
How is the financial situation around Malaria?
“It is great how much money is available these days to fight diseases such as malaria, tuberculosis or aids. The Global…
World Malaria Day 2023 and the gene drives deception
World Malaria Day 2023 and the gene drives deception
At the occasion of World Malaria Day (25 April), the Stop Gene Drives Campaign encourages you to take a closer look at the insights and perspectives shared by prominent actors and other organisations closely monitoring the subject on this significant day.
By 2030, the World Health Organization (WHO) hopes to reduce the global malaria…
International negotiations on Gene Drives resume in person
15.04.22, Berlin -The UN Convention on Biological Diversity (UN CBD) and its sub-protocols are the world's most important forums for establishing internationally binding regulations for Gene Drive technology. For the first time since the beginning of the COVID pandemic - after more than two years of repeated postponements and online meetings - government officials, civil society, scientists and…
Seminar and Press Conference on Gene Drives in Nairobi
This morning, Friday 17th of May, Save Our Seeds with Pollinis hosted a hybrid seminar on GMOs and gene drives. This event offered an exceptional opportunity to gain insights into the political landscape surrounding GMOs and the increasingly contentious topic of gene drives currently under consideration at the United Nations Convention on Biological Diversity. Our expert speakers, fresh from the…
Seminar and Press Conference on Gene Drives in Nairobi
This morning, Friday 17th of May, Save Our Seeds with Pollinis hosted a hybrid seminar on GMOs and gene drives. This event offered an exceptional opportunity to gain insights into the political landscape surrounding GMOs and the increasingly contentious topic of gene drives currently under consideration at the United Nations Convention on Biological Diversity. Our expert speakers, fresh from the…
Seminar und Pressekonferenz zu Gene Drives in Nairobi
Am heutigen Morgen, Freitag, den 17. Mai, veranstalteten Save Our Seeds in Zusammenarbeit mit Pollinis ein hybrides Seminar über gentechnisch veränderte Organismen (GMOs) und Gene Drives. Diese Veranstaltung bot eine außergewöhnliche Gelegenheit, Einblicke in die politische Landschaft rund um GMOs und das zunehmend umstrittene Thema der Gene Drives zu gewinnen, die derzeit auf der Konvention über…
European Parliament: no promotion of genetic technologies in development policy!
On Oct. 6, 2021, the European Parliament, in its plenary session, called on the EU Commission and EU member states, through its report on "The role of development policy in combating biodiversity loss in developing countries in the context of the implementation of the 2030 Agenda, "to actively protect the rights of future generations, not to promote genetic technologies with development aid funds…
Interview with Lucile Cornet-Vernet
Gene Drives will most probably be released first to fight malaria. We therefore created this series of interviews with health care experts, researchers and civil society to amplify their voices and concerns around this technology.
How did you get to work on malaria and what are you doing?
Lucile Cornet-Vernet is the founder of “La Maison de l'Artemisia” (engl.: the house of artemisia) founded…
The need for horizon scanning and technology assessment to address the evolving nature of genetic engineering
This is an excerpt of a Briefing Paper by Third World Network published in June 2022
Introduction
The governance and regulation of advancing life and agricultural sciences is lagging behind technical innovations and our evolving understanding of the science underpinning genetic engineering technologies. Such technologies, mainly in the form of transgenic techniques, were first commercialized…
SBSTTA 26: Robust risk assessment needed for LMOs containing engineered gene drives
As participants in the 26th Subsidiary Body on Scientific, Technical, and Technological Advice (SBSTTA 26) of the UN Convention on Biological Diversity (CBD), we will be sharing insights through articles authored by members of the CBD-Alliance's Working Group on Synthetic Biology, to which we belong.
Key topics of discussion at the Nairobi conference include synthetic biology and the risk…